pipette
ESEspañol

Permissive Blood Pressure Targets in Pediatric Critical Care

David Philip Inwald, Emma Laing, Julia M. Broomhall, Tommaso Viola, Carly Au, Alanna Brown, Julie Camsooksai, Irene Chang, Hannah Chester, Robert B. Darnell, Prabhleen Ghattoray, Amelia Francis Johnson, Stef Keattch, Millie Parke, Joseph Charles Manning, Padmanabhan Ramnarayan, Samiran Ray, Zia Sadique, Barnaby R. Scholefield, Dermot Shortt, Karen E. Thomas, Helen Winmill, David A Harrison, Mark J. Peters, Kathy M. Rowan, Paul R. Mouncey, Protocolised Evaluation of Permissive Blood Pressure Targets Versus Usual Care (PRESSURE) Trial Investigators on behalf of the United Kingdom Paediatric Critical Care Society Study Group (PCCS-SG), Deborah K. White, Esther Daubney, Ben Lakin, Simon Davies, Laura O’Malley, Paris Lucia Harrison, Afeda Mohamed Ali, Jane V. Cassidy, Samantha Finn, Sarah Fox, Carly Tooke, Rachel Lewis, Alvin W. L. Schadenberg, Laura Dodge, Judit Bak, Elizabeth Stoddart, Sandra Walsh, Mong Hoi Tan, Ellen McGarr, Jocelyn Thekkudan, Elisabeth Day, Rachel Agbeko, Robert Claydon and 10 more

Peer-reviewed journalReal-world use

In the authors' words

This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.

Main result
Conclusions and Relevance: Adopting a permissive MAP target resulted in no significant difference in mortality and duration of invasive ventilation at 30 days compared with usual care.

Appeared: Wednesday, September 30. JAMA. Peer-reviewed journal.

DOI: 10.1001/jama.2026.19747